Staying informed is also a great way to stay healthy. Keep up-to-date with all the latest health news here.
12 Sep
Women with asthma are more likely to experience a miscarriage and fertility issues, according to Danish researchers, but they also appear no less likely to give birth.
11 Sep
Girls exposed to certain endocrine-disrupting chemicals are more likely to start puberty early – increasing their risk for obesity, diabetes and heart disease, researchers say.
10 Sep
A new study finds infants and young kids who eat a lot of fruit, oats and rye have significantly higher odds of being diagnosed with type 1 diabetes, which can lead to eye, heart, nerve and kidney problems.
Smokers who make the decision to quit will see almost immediate health benefits, including a quick drop in their risk for atrial fibrillation, new research shows.
“The findings provide a compelling new reason to show current smokers that it’s not too late to quit and that having smoked in the past doesn’t mean you’r...
Humans could learn a few medical tips from their gorilla cousins, a new study says.
Four plants used by wild gorillas in Gabon have antibacterial and antioxidant properties, researcher reported Sept. 11 in the journal PLOS One.
Wild great apes often self-medicate, consuming medicinal plants that can treat their ailments, res...
Statistics from 2023 on U.S. obesity rates bring no good news: In every state in the nation, 1 in every 5 people is now obese, the new tally shows.
In 2013, not one state had an adult obesity rate topping 35%, but 10 years later 23 states had achieved that dubious distinction, according to data released Thursday by the U.S. Centers for Dis...
It could be a real breakthrough for people at risk for HIV infection: A shot given every six months that reduces their risk by a whopping 96%.
That's according to new trial results released Thursday by Gilead Sciences, which is repurposing its HIV treatment, the antiviral lenacapavir, as a twice-yearly preventive shot.
There's a catc...
An ingredient in the hair dye a French woman used caused her to develop a vision-robbing retinopathy, researchers report.
When she switched to a dye without these ingredients, called aromatic amines, her vision troubles resolved, according to a team led by Dr. Nicolas Chirpaz, an ophthalmologist at Edouard Herriot Hospital, in Lyon.
Prescriptions for amphetamine stimulants to treat ADHD have increased significantly in recent years, particularly during the pandemic.
Unfortunately, high doses of stimulants like Adderall can increase the risk of psychosis or mania by more than fivefold, a new study finds.
Patients had a nearly 63% increased risk of psychosis or man...
The number of Americans with a potentially dangerous heart rhythm condition is three times greater than previously thought, a new study claims.
An estimated 5% of the population -- 10.5 million U.S. adults -- have atrial fibrillation, according to new estimates from the University of California, San Francisco (UCSF).
Previous estimat...
The injectable weight-loss drug Zepbound appears to work better in women than in men, according to a new analysis of the clinical trials that led to its approval.
All doses of tirzepatide consistently reduced weight in both women and men, researchers found.
But women lost up to 25% of their initial body weight when treated with tirze...
A lot of Americans are on the fence regarding annual flu and COVID shots, a new survey finds.
More than one-third of those polled (37%) said they’d gotten vaccines in the past but don’t plan to this year, according to results from a nationwide Ohio State University Wexner Medical Center survey.
Just a slight majority -- 5...
Two monoclonal antibody treatments to slow Alzheimer's disease, lecanemab (Leqembi) and donanemab (Kisunla), have been approved by the U.S. Food and Drug Administration over the past two years.
It's thought the drugs curb Alzheimer's by reducing levels of toxic amyloid protein plaques in the brain.
But what if another neurological ...
Black stroke victims are arriving at emergency rooms much later than white patients, greatly increasing their risk of death or lifelong disability, a new study finds.
Every second counts when it comes to treating a stroke, experts say.
Any moment’s delay allows for more brain damage to occur, and patients could arrive too late ...
Ozempic and Wegovy can prevent heart problems in overweight and obese people, particularly if they also suffer from kidney disease, a new clinical trial shows.
The drugs’ active ingredient, semaglutide, reduced heart health risk by 20% in heavyset people who took it for more than three years, researchers reported Wednesday at the Eur...
Less than half of people who've survived a stroke will go on to have a healthy, normal sleep pattern, new research shows.
Normal sleep is defined as six to eight hours of shuteye nightly. However, a majority of the nearly 1,600 stroke survivors in the new study got either too much or too little sleep.
“Sleeping the right amoun...
As fears of the consequences of an unintended pregnancy rose after Roe v. Wade was overturned in 2022, rates of surgical sterilization rose in those states most affected by the decision, new research shows.
Rates of tubal sterilization -- tying, cutting or removing the fallopian tubes -- rose by an average 3% per month in states where abor...
The U.S. Food and Drug Administration announced Tuesday that it will launch an independent review into any possible effects of toxic metals found in tampons.
The announcement follows the release of a study in July that found traces of lead and other metals in 30 tampons from 14 brands obtained from major online retailers and stores in the ...
The weight-loss drug liraglutide helped obese children lower their BMI and reach a healthier weight, researchers report.
The findings, published Tuesday in the New England Journal of Medicine and presented simultaneously at the European Association for the Study of Diabetes annual meeting in Madrid, are the first to demonstr...
An experimental weight-loss pill appears to help people quickly shed pounds, a new study says.
People who took the drug amycretin lost up to 13% of their body weight over three months, according to early clinical trial results presented at the European Association for the Study of Diabetes annual meeting in Madrid.
Amycretin mimics t...
In the two years since the March of Dimes' last report on the state of U.S. maternity care, more than 100 hospitals nationwide have shuttered their obstetric units, leaving more new moms with literally "Nowhere to Go" for care.
The March of Dimes' 2024 report, titled "Nowhere to Go: Maternity Care Deserts Across the U.S.," finds hospital c...
Weekly insulin shots can help control both type 1 and type 2 diabetes as well as daily injections do, a pair of clinical trials have found.
A new class of insulin called efsitora alfa has been designed to require injections only once a week, researchers said.
Two phase 3 trials presented Tuesday at the European Association for the St...
Contrary to a warning placed on labels for CART-T cancer therapies, use of these treatments does not appear to boost the odds for a secondary cancer later, a new study shows.
Researchers at Memorial Sloan Kettering Cancer Center (MSKC) in New York City believe CAR-T may be safer in that regard than is now assumed, and warning labels may ne...